GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q2 2020

Top Holdings44 positions

Checking export access…
Activity:

TENET HEALTHCARE CORP COM NEW

19.8M$357.9M9.9%$17.82+1.65%
7 qtrssince 2018-Q4
Increased
61
TAKTAK
ADR

TAKEDA PHARMACEUTICAL CO LTD

16.2M$290.4M8.0%$18.88-10.23%
6 qtrssince 2019-Q1
Decreased
0

BAUSCH HEALTH COS INC

15.6M$286.1M7.9%$22.43-18.90%
7 qtrssince 2018-Q4
Decreased
0

CIGNA CORP NEW

1.3M$244.3M6.7%$157.88+6.93%
7 qtrssince 2018-Q4
Decreased
0

HCA HEALTHCARE INC

2.2M$209.4M5.8%$119.49-23.06%
7 qtrssince 2018-Q4
Decreased
0

DXC TECHNOLOGY CO

12M$197.8M5.5%$48.24-65.80%
7 qtrssince 2018-Q4
Increased
66

MCKESSON CORP

1.2M$187M5.2%$105.01+39.58%
7 qtrssince 2018-Q4
Decreased
0
PARAPARADelisted

VIACOMCBS INC

5.8M$134.2M3.7%——
3 qtrssince 2019-Q4
Decreased
0
NUANNUANDelisted

NUANCE COMMUNICATIONS INC

5M$127.6M3.5%——
7 qtrssince 2018-Q4
Decreased
0
734,044$121.9M3.4%$4.100.00%
1 qtr
New
84

F M C CORP

1.1M$114.3M3.2%$52.60+56.85%
7 qtrssince 2018-Q4
Decreased
0
HOLXHOLXDelisted

HOLOGIC INC

1.9M$110.3M3.0%$43.06+23.84%
7 qtrssince 2018-Q4
Decreased
0

MERITOR INC

5.5M$107.9M3.0%——
7 qtrssince 2018-Q4
Decreased
0

AMERISOURCEBERGEN CORP

955,159$96.3M2.7%$71.04+21.90%
7 qtrssince 2018-Q4
Increased
65

IQVIA Holdings Inc.

551,258$78.2M2.2%$115.32+19.25%
7 qtrssince 2018-Q4
Decreased
0

Boston Scientific Corporation

2.1M$74.2M2.0%$32.63+7.60%
2 qtrssince 2020-Q1
Decreased
0

CORTEVA INC

2.5M$67.5M1.9%$25.80-4.97%
3 qtrssince 2019-Q4
Increased
72

HUMANA INC

171,332$66.4M1.8%$250.99+46.02%
7 qtrssince 2018-Q4
Decreased
0

UNIVERSAL HLTH SVCS INC

678,152$63M1.7%$97.79-8.10%
7 qtrssince 2018-Q4
Increased
74

DAVITA INC

787,483$62.3M1.7%$77.210.00%
1 qtr
New
68
$3.6B
AUM
44
Positions
Q2 2020
Filing
HI score · 3.0/5
Quarterly 13F Value Change
+9%Q1'19$11.2B-2%Q2'19$11B-14%Q3'19$9.5B+20%Q4'19$11.4B-68%Q1'20$3.7B-2%Q2'20$3.6B
Activity profile
$ moved · Q2'20
New26%Increased17%Decreased39%Exited18%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.8 quarters
<1Q18%1-4Q23%1-2Y59%2Y+0%

GLENVIEW CAPITAL MANAGEMENT, LLC manages $3.6B across 44 positions as of Q2 2020. Top holdings: THC (9.9%), TAK (8.0%), BHC (7.9%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.

Q2 2020 Summary

Active quarter - 10 new positions, 11 exits, 8 increased. Top move: UHS (INCREASED, conviction 74). Portfolio: $3.6B across 44 positions.

Top holdings by portfolio weight

Total AUM$4B
THC9.87%
TAK8.01%
BHC7.89%
CI6.73%
HCA5.77%
DXC5.45%
MCK5.15%
PARA3.70%
NUAN3.52%
LABORATORY C3.36%
Other3.15%

Portfolio allocation by GICS sector

Sectors8
Healthcare69.63%
Unknown12.32%
Basic Materials5.98%
Technology5.83%
Consumer Cyclical3.10%
Industrials2.77%
Real Estate0.22%
Communication Services0.15%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L65
Conviction48
Concentration88
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
GPNGPNGLOBAL PMTS INC
Q2 2025 → Q2 2026+5.1M shares+$274.8M
4Q
AMZNAMZNAMAZON COM INC
Q3 2025 → Q2 2026+708,813 shares+$179.6M
4Q
EYEEYENATIONAL VISION HLDGS INC
Q3 2025 → Q2 2026+2.3M shares+$40.3M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used